2010 Globe 100 - The Best of Massachusetts Business

Wall Street darlings

Ranked by ratio of market value to revenue. Company must have had stock that traded at or above $5 a share on Dec. 31, 2009, and a market value of $1 million or higher.
Rank Company 2009 revenue (millions Market value (millions) Market value to revenues
1 Metabolix $1.4 $287.8 202.0
2 Vertex Pharmaceuticals $101.9 $8,244.3 80.9
3 AMAG Pharmaceuticals $17.2 $651.6 37.9
4 Clinical Data $13.1 $483.7 37.0
5 Momenta Pharmaceuticals $20.2 $562.3 27.8
6 ImmunoGen $18.7 $448.5 23.9
7 American Tower Corp. $1,724.1 $17,346.7 10.1
8 Senior Housing Properties Trust $297.8 $2,785.8 9.4
9 Franklin Street Properties $130.5 $1,164.1 8.9
10 Sycamore Networks $72.0 $593.8 8.2
SOURCE: Capital IQ, a Standard & Poor's business